About VERITAS IN SILICO INC
Sector
Industry
Headquarters
Tokyo
Website
Founded
2016
ISIN
JP3155340007
FIGI
BBG01KWV5WW9
Veritas In Silico Inc. engages in the development of molecular medicine drugs. It provides a platform business for the discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. The company was founded by Shingo Nakamura on November 17, 2016 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 130A is 1677 JPY — it has increased by 2.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange VERITAS IN SILICO INC stocks are traded under the ticker 130A.
130A stock is 6.58% volatile and has beta coefficient of 0.09. Check out the list of the most volatile stocks — is VERITAS IN SILICO INC there?
Yes, you can track VERITAS IN SILICO INC financials in yearly and quarterly reports right on TradingView.
130A stock has risen by 1.51% compared to the previous week, the month change is a 16.15% fall, over the last year VERITAS IN SILICO INC has showed a 16.19% decrease.
No, 130A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 130A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERITAS IN SILICO INC stock right from TradingView charts — choose your broker and connect to your account.